Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)

Clinical trial NCT07055399 · RECRUITING

Trial details

NCT number: NCT07055399
Sponsor: Fujian Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cervical Cancer

Start date: 2025-08-21
Primary completion: 2026-09-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.